Life Scientist > Biotechnology

Cancer cells tricked into defective reproduction

15 May, 2019

A 'triple combination' of vitamin C and two standard antibiotics — doxycycline and azithromycin — was sufficient to reduce stem cell growth by more than 90% in laboratory tests.

DNA folded into a nanocapsule for drug delivery

01 May, 2019

Finnish researchers have developed a customised DNA nanostructure that can perform a predefined task in human body-like conditions.

Natural antibiotic genetically engineered from fungus

15 April, 2019

Researchers have used genetic engineering to turn a fungus into a natural antibiotic — one which could serve as a promising cure for a neglected tropical disease.

Ovarian cancer trial shows positive results

11 April, 2019

Kazia Therapeutics has summarised data from Part A of its ongoing phase I study of Cantrixil in ovarian cancer — a study which has so far seen promising results.

Miniature hearts used to test potential new drugs

10 April, 2019

Australian scientists have conducted what is claimed to be the first ever screening of potential heart regeneration drugs using bioengineered human heart muscle.

Anti-TB drugs can actually increase risk of TB reinfection

05 April, 2019

Anti-TB drugs cause changes to gut microbiota, increasing susceptibility to Mycobacterium tuberculosis infection as a result.

Potential male birth control pill passes human safety tests

03 April, 2019

US scientists have announced promising results from their recent trial of an experimental male oral contraceptive.

'Antibiotic envelope' cuts infection risk from cardiac devices

27 March, 2019

Encasing implantable cardiac devices such as pacemakers in a mesh sleeve embedded with antibiotics reduces the risk of major infection by 40%.

Pharmaceutical manufacturing and obsolescence management

19 March, 2019

For many pharmaceutical manufacturing processes, often very old equipment or technology is still being used.

3D bioprinter Koligo Therapeutics to list on ASX

18 March, 2019

Koligo Therapeutics, a regenerative medicine and 3D bioprinting company, will list on the Australian Securities Exchange at the end of March via an initial public offering.

New drug developed to treat heart attack damage

15 March, 2019

UK researchers are working to develop drugs that could be given in the first few hours following a heart attack to minimise heart muscle death caused by the stress signals.

Fungus-based peptide found to kill TB bacteria

11 March, 2019

Researchers have discovered a potential new pharmaceutical candidate for tuberculosis, finding that the antimicrobial peptide NZX rapidly and effectively kills TB bacteria.

Horse sperm can now be stored unfrozen for longer

08 March, 2019

Scientists have developed a nutrient-rich liquid that enables collected horse semen to live for two weeks outside the body without the need to be frozen.

Positive trial results for peanut allergy therapy

01 March, 2019

Trial data showed that Melbourne biotech company Aravax's therapy has a highly favourable safety profile, even in patients with severe peanut allergies.

Antivirals cut liver cancer risk in Hep C patients

28 February, 2019

Direct-acting antivirals have been found to be associated with a reduced risk of liver cancer and death in people with chronic hepatitis C.

  • All content Copyright © 2021 Westwick-Farrow Pty Ltd